Avraham Gabay Oramed Pharmaceuticals Inc. (ORMP) insider trading activity

ORMP Quotes by TradingView

Avraham Gabay is Chief Financial Officer of ORAMED PHARMACEUTICALS INC.. Currently has a direct ownership of 630,256 shares of ORMP, which is worth approximately $1.5 Million. The most recent transaction as insider was on Dec 31, 2025, when has been sold 196,216 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 630K
45.21% 3M change
76.03% 12M change
Total Value Held $1.5 Million

Avraham Gabay Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 31 2025
BUY
Grant, award, or other acquisition
-
196,216 Added 23.74%
630,256 Common Stock
Feb 11 2025
BUY
Grant, award, or other acquisition
-
76,000 Added 14.9%
434,040 Common Stock
Jan 02 2025
BUY
Grant, award, or other acquisition
-
188,000 Added 34.43%
358,040 Common Stock
Nov 07 2024
BUY
Grant, award, or other acquisition
-
30,000 Added 15.0%
170,040 Common Stock
Jun 21 2024
BUY
Grant, award, or other acquisition
-
140,040 Added 100.0%
0 Common Stock
AG

Avraham Gabay

Chief Financial Officer
Jerusalem, L3

Track Institutional and Insider Activities on ORMP

Follow ORAMED PHARMACEUTICALS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORMP shares.

Notify only if

Insider Trading

Get notified when an Oramed Pharmaceuticals Inc. insider buys or sells ORMP shares.

Notify only if

News

Receive news related to ORAMED PHARMACEUTICALS INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ORMP